Products for Research Use Only
RegisterLogin

RG7287

CAT: 0804-HY-P991226-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991226-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
RG7287 is an activating antibody inhibitor targeting human CDCP1. RG7287 prevents the loss of contact inhibition caused by the co-transformation of NIH3T3 cells with CDCP1 and Src in focus formation assays. RG7287 inhibits tumor cell proliferation and leads to a significant reduction in CDCP1 levels[1].
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.666
Smiles
[RG7287]
Precautions
H302, H315, H319, H335
References & Citations
[1]Gwendlyn Kollmorgen, et al. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Mol Oncol. 2013 Dec;7 (6) :1142-51.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P10271-01RG7697

Alternative Products

CatalogName
T9901A-952-01RG7287
GTR18712328-01RG7287 Antibody
PTX25686Anti-Human CD318/CDCP1 (RG7287)
WA1568Research Grade Anti-Human CD318/CDCP1 (RG7287)
A135944Anti-CD318/CDCP1 (RG7287) Biosimilar (Monoclonal, IgG1-kappa)

Popular Products